SOSUM S

Sosum S is a hyaluronic acid (HA)-based dermal filler produced by JSBIO Co., Ltd., a South Korean company. It is specifically designed to address fine lines and superficial wrinkles, providing a subtle enhancement to facial features. The formulation boasts a high cross-linking rate, which contributes to its effectiveness and longevity.

Composition and Characteristics

The primary component of Sosum S is hyaluronic acid at a concentration of 20 mg/ml. The unique formulation includes several key characteristics:

1. High Cross-Linking Rate: This feature enhances the filler’s resistance to degradation, allowing for a longer-lasting aesthetic effect.
2. Zero Residual BDDE: The manufacturing process ensures that there are no residual levels of BDDE (1,4-butanediol diglycidyl ether), which minimizes the risk of allergic reactions and other side effects.
3. Low Endotoxin Levels: This further reduces the likelihood of adverse reactions post-injection.
4. Exceptional Density, Viscosity, and Elasticity: These properties contribute to the filler’s ability to integrate seamlessly with the skin while providing effective hydration and support.

Application Areas

Sosum S is particularly effective in treating various facial areas:

• Forehead and glabellar lines
• Fine perioral lines
• Periorbital area (crow’s feet)
• Neck lines

The aesthetic results from Sosum S can last up to 12 months, making it an appealing option for individuals seeking long-term solutions for fine lines.

Treatment Procedure

The treatment involves injecting Sosum S into the upper dermis using techniques such as linear threading or serial puncture. To enhance comfort during the procedure, a topical anesthetic may be applied beforehand. The low injection force required for this gel allows for uniform distribution without causing significant discomfort.

Safety Profile

Sosum S has undergone toxicity testing, demonstrating proven safety and efficacy based on surveys conducted eight weeks and twenty-four weeks after injection procedures. However, it is contraindicated for individuals with known hypersensitivity to hyaluronic acid, autoimmune diseases, active skin infections or inflammation, pregnancy or lactation status, or those under 18 years of age.